Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir.
Bai, Y., Ye, F., Feng, Y., Liao, H., Song, H., Qi, J., Gao, G.F., Tan, W., Fu, L., Shi, Y.(2021) Signal Transduct Target Ther 6: 51-51
- PubMed: 33542181 
- DOI: https://doi.org/10.1038/s41392-021-00468-9
- Primary Citation of Related Structures:  
7D1O
Organizational Affiliation: 
Savaid Medical School, University of Chinese Academy of Sciences, Beijing, 100049, China.